Lexicon Pharmaceuticals | LXRX - EPS Earnings Per Share

Stock Price
1.31
Daily Change
0 0%
Monthly
5.65%
Yearly
66.90%
Q1 Forecast
2.01

Lexicon Pharmaceuticals reported $-0.17 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Abbott USD 1.5 0.2 Dec/2025
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Akebia Therapeutics USD 0.03 0.13 Mar/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Coherus Biosciences USD -0.35 0.07 Mar/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Halozyme Therapeutics USD 1.72 0.18 Sep/2025
Illumina USD 1.35 0.01 Dec/2025
Insmed USD -1.75 0.05 Sep/2025
Ironwood Pharmaceuticals USD 0.24 0.1 Sep/2025
J&J USD 2.46 0.34 Dec/2025
Lexicon Pharmaceuticals USD -0.17 0.02 Jun/2024
MacroGenics USD 0.27 0.84 Sep/2025
MannKind USD 0.07 0.02 Sep/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Novartis USD 2.04 0.38 Sep/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Thermo Fisher Scientific USD 6.57 0.78 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024